For decades, lithium has been known primarily as a mood stabilizer, prescribed in controlled doses to treat bipolar disorder, mania, and severe depression. But science is now uncovering another side to this mineral — one that could reshape how we understand, detect, and possibly treat Alzheimer’s disease.
A groundbreaking study in Nature has revealed that lithium occurs naturally in the human brain and is essential for normal brain function. More strikingly, researchers found that declining lithium levels may signal the earliest stages of Alzheimer’s, appearing well before severe memory loss takes hold.
The team analyzed brain tissue from people who died with healthy cognition, mild cognitive impairment, or advanced Alzheimer’s. Among 27 trace metals tested, lithium stood out as the only one that differed significantly between groups. In those with early memory loss or Alzheimer’s, lithium levels were markedly lower — and the decline began at the earliest stages of disease.
To probe deeper, scientists turned to a mouse model. Mice deprived of dietary lithium aged more quickly, developed brain inflammation, and showed worsening memory. In mice engineered to develop Alzheimer’s, low lithium accelerated the buildup of amyloid-beta plaques — a hallmark of the disease — and triggered immune cells that can harm brain tissue.
When these mice were given lithium orotate, a form of the mineral that penetrates brain tissue, the results were remarkable: plaque formation slowed, inflammation eased, and memory performance improved.
“This is a new way of thinking about Alzheimer’s,” said Dr. Bruce Yankner, senior author of the study and professor of genetics and neurology at Harvard Medical School. “The idea that a natural deficiency could contribute to the disease opens up a very different therapeutic path. The early data are encouraging, but we need controlled human trials to know if this works in people.”
Dr. Manisha Parulekar, a geriatric medicine specialist who was not involved in the study, said the findings broaden the focus beyond the decades-long effort to simply remove amyloid plaques. “Alzheimer’s isn’t just about one target,” she said. “This suggests that restoring balance to a naturally occurring element in the brain could influence multiple hallmarks of the disease — plaques, tangles, and even cognitive resilience.”
In her view, lithium therapy could one day be used much like preventive heart care: starting early to preserve brain health, or even after symptoms begin, to protect surviving neurons and slow further decline.
Neurologist Dr. Peter Gliebus echoed that cautious optimism. “If these results hold true in humans, measuring brain lithium could become a biomarker for early detection,” he said. “And targeted replacement therapy might help slow — or even halt — disease progression in its earliest stages.”
While researchers stress that lithium supplements should not be self-prescribed — the doses used in treatment are far higher than those found naturally in the brain — the work offers a tantalizing possibility: that a simple mineral, quietly supporting our neurons for a lifetime, could become a powerful ally in the fight against one of the most feared diseases of aging.
